Ali Health's stock price plummeted 5.29% during the intraday session on Friday.
The sharp decline followed the release of the company's FY2026 annual results, which showed a gross margin of 24%, falling short of the market consensus estimate of 24.6%. This raised concerns over the quality of earnings despite reported growth in revenue and net profit.
Adding to investor uncertainty, the company simultaneously announced the resignation of CFO Tu Yanwu, effective immediately, with Sheng Mengyue appointed as the successor. The broader internet healthcare sector also faced selling pressure during the session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments